Oral Wegovy vs Foundayo in Detroit, MI: Daily Weight Loss Pills Compared
Oral Wegovy vs Foundayo in Detroit, MI: Daily Weight Loss Pills Compared
Two FDA-approved daily pills for chronic weight management are now available to adults: oral Wegovy (semaglutide tablets) and Foundayo (orforglipron). If you would rather not take an injection, this guide shows how the two differ in practice. Which one fits you is a decision for you and your physician.
Medically reviewed by Dr. Diala Alatassi, MD, DABIM, DABOM, FACP. Last reviewed: October 2026.
Next step: Take the 2-minute eligibility quiz to see whether you qualify. There is no charge and no credit card is required. If you move forward, the video consultation is $99.
Side by side
| Oral Wegovy | Foundayo | |
|---|---|---|
| Active ingredient | Semaglutide | Orforglipron |
| Class | GLP-1 receptor agonist | GLP-1 receptor agonist |
| Form | Once-daily pill | Once-daily pill |
| Food and timing rules | Take in the morning on an empty stomach with no more than 4 ounces of plain water, then wait at least 30 minutes before eating, drinking or taking other oral medicines | Swallow whole, with or without food |
| Dose steps | 1.5 mg, then 4 mg, then 9 mg, each for 30 days, then 25 mg maintenance | Starts at 0.8 mg daily and is raised at least every 30 days as tolerated, up to a maximum of 17.2 mg |
| Other labeled uses | Lowers risk of major cardiovascular events in adults with established cardiovascular disease and obesity or overweight | Chronic weight management |
| Our guide | Oral Wegovy in Detroit | Foundayo in Detroit |
Everyday differences
- Morning routine. Oral Wegovy needs an empty stomach and a 30-minute wait, which suits some routines and frustrates others. Foundayo has no food or timing rule.
- Dose escalation. Both are raised in steps over time to limit stomach side effects.
- Heart disease. Oral Wegovy carries a labeled cardiovascular risk-reduction use in adults with established cardiovascular disease and obesity or overweight.
- Cost and coverage. Insurers and cash prices differ. See the cost guide and insurance guide.
Safety basics
As with other GLP-1 medicines, the most common side effects are nausea, vomiting, diarrhea, constipation and abdominal discomfort. People with a personal or family history of medullary thyroid carcinoma or MEN 2, and people who are pregnant, should not use these medicines. Read the full labels and talk with your physician about your history.
FAQs
Are pills as effective as injections?
Average results differ by medicine and by trial, and trials are not directly comparable. Your physician can walk through the numbers on each label and help you weigh convenience against expected benefit.
Do I take a pill instead of seeing a doctor?
No. Both are prescription medicines. A Michigan-licensed physician evaluates your health history first and follows you monthly by video.
Where do I fill the prescription?
At the pharmacy you choose. TeleSlim Clinic does not dispense medication.
Related guides
- Oral Wegovy (semaglutide pill)
- Foundayo (orforglipron)
- Weekly injection vs daily pill
- Zepbound vs Wegovy
- Weight loss medication cost in Detroit, MI
- Online weight loss doctor in Detroit, MI
Sources and further reading
- Wegovy (semaglutide) prescribing information, DailyMed (U.S. National Library of Medicine)
- Foundayo (orforglipron) prescribing information, DailyMed (U.S. National Library of Medicine)
Links open third-party sites. Prescribing information is the authoritative source for approved uses, dosing and safety.
Meet your physician
Dr. Diala Alatassi, MD, DABIM, DABOM, FACP is Chief Medical Officer of TeleSlim Clinic. She is board-certified in Internal Medicine and Obesity Medicine and is licensed to practice in Michigan. All TeleSlim Clinic visits are conducted by video with a board-certified physician.
Take the 2-minute eligibility quiz to see whether you qualify. If you move forward, the video consultation is $99 and monthly physician follow-up is $99.
This page is general education, not medical advice. Whether a medication is appropriate is a decision made by a physician after an evaluation. Individual results vary.



